There are 2949 resources available
LBA29 - Individualized starting dose of niraparib in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC): A randomized, double-blind, placebo-controlled, phase III trial (NORA)
Presenter: Xiaohua Wu
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA30 - INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
Presenter: Nicoletta Colombo
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
Invited Discussant 1214O and 1215O
Presenter: Lyudmila Bazhenova
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lyudmila Bazhenova
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Webcast
Invited Discussant LBA84 and 1783O
Presenter: Corinne Faivre-Finn
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lyudmila Bazhenova
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Webcast
Invited Discussant LBA38, 910O and LBA39
Presenter: Sjoukje Oosting
Session: Proffered Paper - Head & Neck cancer
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Anthony T.C. Chan
Session: Proffered Paper - Head & Neck cancer
Resources:
Webcast
Invited Discussant LBA40 and 911O
Presenter: Christian Simon
Session: Proffered Paper - Head & Neck cancer
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Anthony T.C. Chan
Session: Proffered Paper - Head & Neck cancer
Resources:
Webcast